A Multicenter, Single-Blind, Active and Placebo-Controlled, Parallel-Group, Randomized Study of Two Dosing Regimens of Enteric Coated Sevelamer in Patients With Mild to Moderate Hypercholesterolemia.

Trial Profile

A Multicenter, Single-Blind, Active and Placebo-Controlled, Parallel-Group, Randomized Study of Two Dosing Regimens of Enteric Coated Sevelamer in Patients With Mild to Moderate Hypercholesterolemia.

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Aug 2013

At a glance

  • Drugs Sevelamer (Primary) ; Colesevelam
  • Indications Hypercholesterolaemia
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms ELLS
  • Sponsors Genzyme Corporation
  • Most Recent Events

    • 02 Mar 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Aug 2008 Status changed from initiated to recruiting (information from ClinicalTrials.gov).
    • 01 Jul 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top